Pharmaceuticals - Community Register

  

List of refusals for human medicinal products

Viviq

Product name: Viviq
INN: Propentofylline
Indication: Treatment of Alzheimer's disease
Marketing Authorisation Holder: Aventis Pharma Deutschland GmbH

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/09/1999 Centralised - Refusal of marketing authorisation EMEA/H/C/147 (1999)3010 of 15/09/1999